Seven-T clears way for noninvasive bone biopsy
The normal micro-architecture of trabecular bone at the distal tibia is evident in an image obtained using FIESTA_C and parallel imaging at 7T (right) on a GE Signa.
The normal micro-architecture of trabecular bone at the distal tibia is evident in an image obtained using FIESTA_C and parallel imaging at 7T (right) on a GE Signa. Studies at this field strength by Sharmila Majumdar, Ph.D., and the musculoskeletal and quantitative imaging research group at the University of California, San Francisco, emerged as a consequence of studies at 1.5T. Images at 1.5T of a patient with osteoporosis demonstrate the degradation of trabecular bone indicative of disease progression, according to group director Majumdar. This work is establishing the foundation on which she hopes to build MR as a noninvasive biopsy tool for gauging the strength of bone in patients suspected of osteoporosis. (Provided by S. Majumdar)
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
